Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
Experts said millions of people across the country are prescribed a medicine for moderate to severe acute pain each year, so ...
The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...
Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex ...
Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
Among significant research news last week, US biotech Allakos reported that it was dropping development of its urticaria ...
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...
What is the significance of topics such as the Ease of Doing Business (EoDB), deregulation, challenges posed by AI, and NIPUN Bharat Mission have on both the UPSC preliminary and main exams? You can ...